

Our services
A complete approach
for inclusive clinical trials
Representative clinical research is a multi-faceted process. As well as the latest research facilities and expertise, you need outreach that works harder to engage a diverse range of participants. All underpinned by experienced planning that combines regulatory knowledge with the ability to see the barriers to inclusion and innovate at the point of need.
At Frontier, we cover this process
from start to finish.
Research sites
Participant
engagement &
recruitment
Functional
Service
Provision
Diversity plan
writing

Research sites
Run your trial through our centrally managed site network, optimised for accessibility and efficiency.
This includes:
- Use of e-Technology (CTMS, eConsent, eCoA etc)
- In-house monitoring and quality assurance
- Centralised management
- Project management
- Budget and CTA negotiations
- Invoicing and payments
- Monitoring and safety oversight.

Participant engagement and recruitment
Connect to participants faster with our unique, ongoing engagement in the community.
- Access to over five million electronic medical records (EMR)
- Non-stop community outreach
- Growing database of trial volunteers
- Working with disease associations
- AI-powered participant identification
- Bespoke, sustained retention
- Focus groups and market research.

Functional Service Provision
Get expert support with a range of customised defined services at every stage of your trial.
- Regulatory and ethics submissions
- Medical monitoring
- Project management
- Medical writing
- Clinical trial monitoring
- Quality assurance
- Commercialisation.

Diversity plan writing
Meet specific FDA or organisation requirements with our diversity plan writing service.
- An overview of the disease or condition among different underrepresented groups
- Assessing how the development program and trial design may affect participant diversity
- The goals for enrolling participants from underrepresented populations
- The specific plan for achieving enrolment goals, including strategies for plan implementation and reporting.
Post submission
We can also assist with submitting enrolment progress reports to the FDA, as required under the new legislation.